HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based on data from clinical trials that showed 99.9% of participants who received it remained HIV negative. Daniel O’Day, Gilead’s chairman and chief executive officer, called…

Read More
4/13: Face the Nation - CBS News

4/13: Face the Nation – CBS News

4/13: Face the Nation – CBS News Watch CBS News This week on “Face the Nation with Margaret Brennan,” U.S. trade representative Jamieson Greer and Minneapolis Fed president Neel Kashkari discuss the latest with the U.S. economy. Plus, the FDA’s former top regulator, Dr. Peter Marks, joins. Be the first to know Get browser notifications…

Read More